dulaglutide semaglutide Dosing Patterns of and in Patients with Type 2 Diabetes Mellitus in France and Italy: A Retrospective Cohort Study | Advances in Therapy Dulaglutide, #semaglutide, and #tirzepatide showed

Public Health England: Health matters: obesity and the food environment

Emerging research is demonstrating that taking Ozempic may cause blindness related to NAION in rare instances

The semaglutide onset timeline and tirzepatide onset timeline help you understand when to expect results once you start

L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)--a randomized multicentre trial

GLP-1 RAs are more than weight-loss medications

WHO Director-General Tedros Adhanom Ghebreyesus said the new guidance "recognizes that obesity is a chronic disease that can be treated with comprehensive and lifelong care." WATCH | Do drugs like Ozempic kill your desire for more than just food?: He added that although medication alone cannot solve this global health crisis, GLP-1 medication could help millions overcome this condition and reduce its associated harms